T-lymphocyte depleted transplants for inborn errors of immunity.
M A SlatterM A MaschanAndrew R GenneryPublished in: Expert review of clinical immunology (2023)
Pharmacokinetic monitoring of serotherapy agents, and use of co-stimulatory molecule blockade are likely to become more widespread. Post-transplant cyclophosphamide or TCR depletion strategies are likely to become the dominant methods of transplantation for nonmalignant diseases.